U.S. market Closed. Opens in 1 day 14 hours 16 minutes

INAB | IN8bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue2.50M1.10M251.00K96.00K96.00KN/A
Gross Profit-2.50M-1.10M-251.00K-96.00K-96.00KN/A
Operating Expenses30.34M28.52M14.65M8.56M5.07M2.00M
Selling, General & Admin13.51M14.46M7.31M3.18M2.71M1.42M
Research & Development16.83M14.06M7.35M5.38M2.36M581.00K
Other Operating Expenses16.83MN/AN/AN/AN/A-63.00K
Operating Income-30.34M-28.52M-14.65M-8.56M-5.13M-2.00M
Other Expenses / Income330.00KN/AN/AN/A-68.00K-63.00K
Before Tax Income-30.01M-28.52M-14.65M-8.56M-5.13M-2.08M
Income Tax Expenses-32.84M-1.10M551.44K-118.30K-68.00K-63.00K
Net Income-30.01M-27.42M-14.65M-8.56M-5.13M-2.08M
Interest ExpensesN/A-1.10MN/AN/AN/A14.00K
Basic Shares Outstanding29.86M20.97M18.78M19.35M19.35M6.17M
Diluted Shares Outstanding29.86M20.97M18.78M19.35M19.35M6.17M
EBITDA-28.50M-28.52M-13.87M-8.47M-4.97M-1.97M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-62.84M-29.62M-14.10M-8.68M-5.20M-2.13M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙